태후메디칼
태후메디칼's KOBDi Score is 30.24 as of Sep 2026, up 0.32 points since Apr 2025; it rose in 2 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 88% of companies in its industry, against 88% in Aug 2026 and 85% in Apr 2025. Its strongest position was 88% (Sep 2026) and its weakest 85% (Apr 2025).
A year earlier, in Aug 2025, its score was 30.08 and it was ahead of about 87% of companies in its industry.
| Sep 2026 | 30.24 | ahead of 88% |
| Aug 2026 | 30.24 | ahead of 88% |
| Jul 2026 | 30.24 | ahead of 88% |
| Jun 2026 | 30.24 | ahead of 88% |
| May 2026 | 30.24 | ahead of 88% |
| Apr 2026 | 30.08 | ahead of 88% |
| Mar 2026 | 30.08 | ahead of 88% |
| Feb 2026 | 30.08 | ahead of 88% |
| Dec 2025 | 30.08 | ahead of 88% |
| Aug 2025 | 30.08 | ahead of 87% |
| Jul 2025 | 30.08 | ahead of 86% |
| May 2025 | 30.08 | ahead of 86% |
| Apr 2025 | 29.92 | ahead of 85% |
Where is 태후메디칼 located?
태후메디칼 is registered at 대구광역시 달서구 용산로, South Korea (postal code 41004).
What industry is 태후메디칼 in?
태후메디칼 belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Pharmaceutical wholesaler.
How many employees does 태후메디칼 have?
태후메디칼 has 5–9 employees.
What is 태후메디칼's KOBDi Score?
30.24 as of September 2026, ahead of about 88% of companies in its industry.
Who are 태후메디칼's competitors?
Similar companies include 인헌약품, ACEPHARM and bto.
